At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 10 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Oxytocin 10 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Intramuscular Oxytocin on Sensory Function in Healthy Volunteers With Ultraviolet Burn Injury to the Skin
In Brief
A Phase 4 clinical trial evaluating Oxytocin and Saline for Chronic Pain. Completed, enrolled 10 participants across 1 site.
Detailed Summary
This study proposes to evaluate the effects that a dose of oxytocin given by intramuscular (IM) injection (into the muscle) will have on an area of skin that has been exposed to ultraviolet (UV) light. The area of skin exposed to UV light will have a mild sun burn feeling. Sensory testing will be performed on the area of UV burn. The area will be evaluated for sensitivity in 3 methods: touch, vibratory
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedMay 2019
Enrollment StartAug 2019
Primary CompletionMar 2020
Study CompletionApr 2020
TodayJul 2026
First PostedMay 2, 2019
Enrollment StartAug 8, 2019
Primary CompletionMar 15, 2020
Study CompletionApr 30, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.2 years ago
Interventions
Oxytocindrug
10 IU oxytocin (Pitocin) for intramuscular injection
Salinedrug
1.5 ml preservative free saline for intramuscular injection